State Street’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $100M | Buy |
1,720,533
+227,983
| +15% | +$10.5M | ﹤0.01% | 1369 |
|
|
2025
Q4 | $66.9M | Buy |
1,492,550
+26,083
| +2% | +$1.1M | ﹤0.01% | 1586 |
|
|
2025
Q3 | $58.9M | Buy |
1,466,467
+86,007
| +6% | +$3.03M | ﹤0.01% | 1645 |
|
|
2025
Q2 | $43.2M | Buy |
1,380,460
+1,074,840
| +352% | +$35.1M | ﹤0.01% | 1752 |
|
|
2025
Q1 | $10.3M | Buy |
305,620
+16,898
| +6% | +$642K | ﹤0.01% | 2512 |
|
|
2024
Q4 | $11.3M | Buy |
288,722
+9,209
| +3% | +$381K | ﹤0.01% | 2554 |
|
|
2024
Q3 | $11M | Buy |
279,513
+32,701
| +13% | +$1.32M | ﹤0.01% | 2544 |
|
|
2024
Q2 | $9.62M | Buy |
246,812
+4,172
| +2% | +$167K | ﹤0.01% | 2582 |
|
|
2024
Q1 | $10.4M | Buy |
242,640
+15,600
| +7% | +$718K | ﹤0.01% | 2562 |
|
|
2023
Q4 | $10.5M | Buy |
227,040
+14,670
| +7% | +$518K | ﹤0.01% | 2567 |
|
|
2023
Q3 | $7.25M | Sell |
212,370
-180
| -0.1% | -$6.73K | ﹤0.01% | 2750 |
|
|
2023
Q2 | $8.18M | Buy |
212,550
+5,094
| +2% | +$202K | ﹤0.01% | 2751 |
|
|
2023
Q1 | $7.42M | Buy |
207,456
+10,020
| +5% | +$370K | ﹤0.01% | 2817 |
|
|
2022
Q4 | $7.78M | Buy |
197,436
+27,065
| +16% | +$986K | ﹤0.01% | 2841 |
|
|
2022
Q3 | $6.15M | Sell |
170,371
-26,850
| -14% | -$965K | ﹤0.01% | 2958 |
|
|
2022
Q2 | $6M | Buy |
197,221
+25,234
| +15% | +$763K | ﹤0.01% | 3007 |
|
|
2022
Q1 | $5.26M | Buy |
171,987
+10,738
| +7% | +$321K | ﹤0.01% | 3155 |
|
|
2021
Q4 | $5.04M | Buy |
161,249
+13,802
| +9% | +$412K | ﹤0.01% | 3237 |
|
|
2021
Q3 | $2.25M | Buy |
147,447
+16,852
| +13% | +$293K | ﹤0.01% | 3576 |
|
|
2021
Q2 | $2.43M | Buy |
130,595
+32,507
| +33% | +$599K | ﹤0.01% | 3512 |
|
|
2021
Q1 | $1.76M | Buy |
98,088
+4,702
| +5% | +$79.7K | ﹤0.01% | 3487 |
|
|
2020
Q4 | $1.44M | Buy |
93,386
+3,839
| +4% | +$44.9K | ﹤0.01% | 3480 |
|
|
2020
Q3 | $991K | Buy |
89,547
+2,883
| +3% | +$33.9K | ﹤0.01% | 3440 |
|
|
2020
Q2 | $1.09M | Buy |
86,664
+67,686
| +357% | +$861K | ﹤0.01% | 3400 |
|
|
2020
Q1 | $215K | Sell |
18,978
-1,382
| -7% | -$19.7K | ﹤0.01% | 3560 |
|
|
2019
Q4 | $267K | Sell |
20,360
-304
| -1% | -$3.2K | ﹤0.01% | 3602 |
|
|
2019
Q3 | $186K | Hold |
20,664
| – | – | ﹤0.01% | 3617 |
|
|
2019
Q2 | $204K | Hold |
20,664
| – | – | ﹤0.01% | 3613 |
|
|
2019
Q1 | $210K | Sell |
20,664
-624
| -3% | -$5.29K | ﹤0.01% | 3570 |
|
|
2018
Q4 | $134K | Buy |
21,288
+1,788
| +9% | +$15.9K | ﹤0.01% | 3613 |
|
|
2018
Q3 | $257K | Buy |
+19,500
| New | +$226K | ﹤0.01% | 3568 |
|
Other funds holding XENE
ACA
DCM
PCH
